Welcome!

News Feed Item

Pro-Dex, Inc. Announces Fiscal 2014 Second Quarter Results

IRVINE, Calif., Feb. 6, 2014 /PRNewswire/ -- Pro-Dex, Inc. (NasdaqCM: PDEX) today announced financial results for its fiscal 2014 second quarter ended December 31, 2013.

(Logo: http://photos.prnewswire.com/prnh/20111025/LA93174LOGO-c)

Quarter Ended December 31, 2013

Net sales for the three months ended December 31, 2013 decreased $367,000, or 12%, to $2.6 million from $3.0 million for the three months ended December 31, 2012 due primarily to decreases of $428,000 in medical device development and manufacturing revenues, and $48,000 in motion control product revenues, which were partially offset by an increase of $152,000 in dental product revenues.

Contributing to the $428,000 decrease related to the Company's medical device product line was a $275,000 decrease in repair revenues from its former largest customer, which was partially offset by an increase of $161,000 in product and repair revenues from its current largest customer.  Pursuant to an agreement with the former largest customer, which commits that customer to a minimum amount of inventory purchases at the agreement's termination in June 2014, the Company expects sales to that customer to continue to decline through the agreement's term, after which it expects no further revenues from that customer.  The increase in sales to the Company's current largest customer reflects the resumption of orders from that customer, which had been curtailed since March 2013.  The Company expects to continue receiving such orders through December 2014, the termination date of that customer's current purchase commitment.  Negotiations for future arrangements with that customer have not yet commenced.  Medical device sales to other customers decreased $181,000 and medical device design revenues decreased $133,000.

Gross profit for the three months ended December 31, 2013 decreased $484,000, or 47%, to $549,000 from $1.0 million for the same period in 2012.  Contributing to this decrease were the reduction in sales volume, described above, and the effects of unfavorable changes in the mix of product sales, which reduced gross profit by $126,000 and $139,000, respectively.  Also contributing to the decrease in gross profit was an increase of $199,000 in the accrual for anticipated losses from the development services portion of certain contracts, and an increase of $166,000 in unfavorable production variances related to reduced manufacturing volumes, which were partially offset by a decrease of $60,000 in warranty expense.  Other than the reduction in sales volume, the factors affecting gross profit described above also resulted in a decrease of gross margin as a percentage of sales to 21% for the three months ended December 31, 2013 from 34% for the corresponding period in 2012.   

Operating expenses (which include selling, general and administrative, and research and development expenses) for the quarter ended December 31, 2013 decreased 35% to $925,000 from $1.4 million in the prior year's corresponding quarter, reflecting primarily the effects of the Company's cost reduction program.

Loss from continuing operations for the quarter ended December 31, 2013 was $338,000, compared to a loss from continuing operations of $364,000 in the corresponding quarter in 2012.  Net loss for the quarter ended December 31, 2013 was $338,000, or $0.10 per diluted share, compared to a net loss of $348,000, or $0.11 per diluted share, for the corresponding quarter in 2012.

Six Months Ended December 31, 2013

Net sales for the six months ended December 31, 2013 decreased $1.3 million, or 20%, to $5.2 million from $6.5 million for the six months ended December 31, 2012 due primarily to a decreases of $1.2 million in medical device development and manufacturing revenues, and $341,000 in motion control product revenues, which were partially offset by an increase of $246,000 in dental product revenues.

The $1.2 million decrease related to the Company's medical device product line was comprised of a $201,000 decrease in repair revenues from its former largest customer, and a $679,000 decrease in revenues from its current largest customer.  As discussed in greater detail above, the Company expects sales to its former customer to decline to zero over the balance of fiscal year 2014, and sales to its current largest customer in fiscal year 2014 to exceed prior year amounts pursuant to the resumption of orders from this customer, which commenced in December 2013 after having been curtailed since March 2013.  Also contributing to the decrease in medical device revenues was a $130,000 decrease in product sales to other medical device customers, and a $175,000 decrease in medical device design revenues.  

Gross profit for the six months ended December 31, 2013 decreased $775,000, or 34%, to $1.5 million from $2.3 million for the same period in 2012.  Contributing to this decrease were the reduction in sales volume described above and the effects of unfavorable changes in the mix of product sales, which reduced gross profit by $493,000 and $143,000, respectively.  Also contributing to the decrease in gross profit was an increase of $212,000 in the accrual for anticipated losses from the development services portion of certain contracts, and an increase of $198,000 in unfavorable production variances related to reduced manufacturing volumes, which were partially offset by a decrease of $213,000 in warranty expense resulting from lower sales volume in the 2013 period, relative to the 2012 period, and the warranty expiration in the 2013 period related to units sold in prior years.  Other than the reduction in sales volume, the factors affecting gross profit described above also resulted in a decrease of gross margin as a percentage of sales to 29% for the six months ended December 31, 2013 from 35% for the corresponding period in 2012.   

Operating expenses (which include selling, general and administrative, and research and development expenses) for the six months ended December 31, 2013 decreased 32% to $1.8 million from $2.7 million in the prior year's corresponding period, reflecting primarily the effects of the Company's cost reduction program.

Loss from continuing operations for the six months ended December 31, 2013 was $320,000, compared to a loss from continuing operations of $418,000 for the corresponding period in 2012.  Net loss for the six months ended December 31, 2013 was $126,000, or $0.04 per diluted share, compared to a net loss of $365,000, or $0.11 per diluted share, for the corresponding period in 2012. 

CEO Comments

Harold A. ("Hal") Hurwitz, the Company's President and Chief Executive Officer, commented, "Our results for the quarter ended December 31, 2013 were materially influenced by factors adversely affecting gross margins.  As we have previously publicly discussed, much of our activity this fiscal year relates to the engineering phase of projects to develop a next-generation platform for powered surgical instruments that we believe will result in manufacturing revenues commencing at the end of fiscal 2014 or early fiscal 2015. Most development efforts of this nature, however, have inherent unexpected costs, and the projects in which we are engaged are no different.  We anticipate that our development project costs will exceed the development project revenues we expect to earn.  Accordingly, we recorded accruals for these excess costs, amounting to $199,000 for the quarter and $212,000 for the six months ended December 31, 2013, that eroded gross margins for those respective periods." 

"In addition, we incurred unfavorable manufacturing variances for the quarter and six months ended December 31, 2013 as a consequence of our relatively low sales volumes that also eroded gross margins.  While it is desirable to maintain manufacturing capacity in anticipation of future activity, we may reduce this capacity as necessary to staunch these unfavorable variances."

"With our cost footprint now right-sized, as evidenced by our year-over-year operating expense performance, the fundamental agenda for Pro-Dex is unchanged – to rebuild our revenue base.  To this end, we have restructured our business development capabilities this fiscal year to more efficiently identify and pursue additional business opportunities, and I look forward to reporting on the results of these initiatives in the future."  

Teleconference Information:

Investors and analysts are invited to listen to a broadcast review of the Company's fiscal 2014 second quarter financial results today at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) that may be accessed by visiting the Company's website at www.pro-dex.com.  The conference call may also be accessed at www.InvestorCalendar.com. Investors and analysts who would like to participate in the conference call may do so via telephone at (877) 407-8033, or at (201) 689-8033 if calling from outside the U.S. or Canada.

For those who cannot access the live broadcast, a replay will be available approximately two hours after the completion of the call until midnight (Eastern Time) on February 20, 2014 by calling (877) 660-6853, or (201) 612-7415 if calling from outside the U.S. or Canada, and then entering conference I.D. number 13575542.  An online archive of the broadcast will be available on the Company's website www.pro-dex.com for a period of 365 days.

About Pro-Dex, Inc.:

Pro-Dex, Inc., with operations in California and Oregon, specializes in the design, development and manufacture of powered rotary drive surgical and dental instruments used primarily in the orthopedic, spine, maxocranial facial and dental markets.  Its OMS division designs and manufactures embedded motion control systems serving the medical, dental, semi-conductor and scientific research markets. Pro-Dex's products are found in hospitals, dental offices, medical engineering labs, scientific research facilities and high tech manufacturing operations around the world. For more information, visit the Company's website at www.pro-dex.com.

Statements herein concerning the Company's plans, growth and strategies may include 'forward-looking statements' within the context of the federal securities laws. Statements regarding the Company's future events, developments and future performance, as well as management's expectations, beliefs, plans, estimates or projections relating to the future, are forward-looking statements within the meaning of these laws. The Company's actual results may differ materially from those suggested as a result of various factors. Interested parties should refer to the disclosure concerning the operational and business concerns of the Company set forth in the Company's filings with the Securities and Exchange Commission.

(tables follow)

 


PRO-DEX, INC. and SUBSIDIARIES


CONDENSED CONSOLIDATED BALANCE SHEETS


(unaudited)














December 31, 2013


June 30, 2013


ASSETS










Current assets:






Cash and cash equivalents

$  1,554,000


$  1,680,000



Accounts receivable, net of allowance for doubtful accounts of $31,000 at December 31, 2013 and $24,000 at June 30, 2013

1,580,000


1,339,000



Unbilled receivables

611,000


244,000



Other current receivables

43,000


32,000



Inventories

3,552,000


3,834,000



Prepaid expenses

168,000


157,000



Income taxes receivable

7,000


2,000



Deferred income taxes

60,000


59,000



Total current assets

7,575,000


7, 347,000


Investments

903,000


370,000


Equipment and leasehold improvements, net

1,794,000


2,065,000


Real estate held for sale


733,000


Intangibles

40,000



Other assets

77,000


80,000


Total assets

$ 10,389,000


$ 10,595,000


LIABILITIES AND SHAREHOLDERS' EQUITY





Current liabilities:






Accounts payable

$  626,000


$      844,000



Accrued expenses

1,089,000


1,276,000



Deferred revenue

247,000


141,000



Income taxes payable

48,000


48,000



Capital lease obligations

7,000


5,000



Total current liabilities

2,017,000


2,314,000


Non-current liabilities:






       Deferred income taxes

60,000


59,000



Deferred rent

253,000


270,000



Capital lease obligations

12,000


15,000



Total non-current liabilities

325,000


344,000


Total liabilities

2,342,000


2,658,000


Commitments and contingencies





Shareholders' equity:






Common shares; no par value; 50,000,000 shares authorized; 3,342,321 and 3,348,184 shares issued and outstanding at December 31, 2013 and June 30, 2013, respectively

17,044,000


17,012,000



Accumulated other comprehensive income

209,000


5,000



Accumulated deficit

(9,206,000)


(9,080,000)



Total shareholders' equity

8,047,000


7,937,000


Total liabilities and shareholders' equity

$             10,389,000


$ 10,595,000












 

PRO-DEX, INC. and SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)

(unaudited)




For The Three Months Ended December 31,

Net sales

2013


2012

$2,640,000


$      3,007,000

Cost of sales

2,091,000


1,974,000

Gross profit

549,000


1,033,000

Operating expenses:




Selling expenses

139,000


322,000

General and administrative expenses

422,000


627,000

Research and development costs

364,000


464,000

Total operating expenses

925,000


1,413,000

Loss from continuing operations before items below

(376,000)


(380,000)

Other expense (income):




Interest expense

2,000


Interest income

(10,000)


Loss from disposal of equipment

6,000


Total other expense (income)

(2,000)


Loss from continuing operations before benefit from income taxes

(374,000)


(380,000)

Benefit from income taxes

(36,000)


16,000

Loss from continuing operations

(338,000)


(364,000)

Income from discontinued operations, net of provision for income taxes of $36,000 in 2013 and $21,000 in 2012

--


(16,000)

Net loss

(338,000)


(348,000)

Other comprehensive income, net of tax




Unrealized gain from marketable equity investments

148,000


--

Total other comprehensive income

148,000


--

Comprehensive loss

$       (190,000)


$      (348,000)

Per share data:




Loss from continuing operations




Basic

$  (0.10)


$            (0.11)

Diluted

$  (0.10)


$            (0.11)

Income from discontinued operations




Basic

$  —


$  —

Diluted

$  —


$  —

Net loss




Basic

$  (0.10)


$  (0.11)

Diluted

$  (0.10)


$  (0.11)

Weighted average shares outstanding - basic

3,343,499


3,319,180

Weighted average shares outstanding - diluted

3,343,499


3,319,180

 

PRO-DEX, INC. and SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)

(unaudited)




For The Six Months Ended December 31,

Net sales

2013


2012

$5,194,000


$      6,468,000

Cost of sales

3,700,000


4,199,000

Gross profit

1,494,000


2,269,000

Operating expenses:




Selling expenses

231,000


596,000

General and administrative expenses

878,000


1,234,000

Research and development costs

740,000


870,000

Total operating expenses

1,849,000


2,700,000

Loss from continuing operations before items below

(355,000)


(431,000)

Other expense (income):




Interest expense

4,000


(6,000)

Interest income

(10,000)


Loss from disposal of equipment

6,000


Total other expense (income)

--


(6,000)

Loss from continuing operations before provision for income taxes

(355,000)


(437,000)

Benefit from  income taxes

(35,000)


(19,000)

Loss from continuing operations

(320,000)


(418,000)

Income from discontinued operations, net of provision for income taxes of $36,000 in 2013 and $25,000 in 2012

194,000


53,000

Net loss

(126,000)


(365,000)

Other comprehensive income, net of tax




Unrealized gain from marketable equity investments

204,000


--

Total other comprehensive income

204,000


--

Comprehensive income (loss)

$78,000


$(365,000)

Per share data:




Loss from continuing operations




Basic

$  (0.10)


$  (0.13)

Diluted

$  (0.10)


$  (0.13)

Income from discontinued operations




Basic

$  0.06


$  0.02

Diluted

$  0.06


$  0.02

Net loss




Basic

$  (0.04)


$  (0.11)

Diluted

$  (0.04)


$  (0.11)

Weighted average shares outstanding - basic

3,344,098


3,299,379

Weighted average shares outstanding - diluted

3,344,098


3,299,379

 

PRO-DEX, INC. and SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(unaudited)




For The Six Months Ended December 31,


2013


2012

Cash flows from operating activities:




Net loss

($126,000)


($365,000)

      Adjustments to reconcile net loss to net cash used in operating activities:




          Depreciation and amortization

283,000


298,000

          Gain on sale of real estate held for sale

(167,000)


          Allowance for doubtful accounts

7,000


-3,000

          Share-based compensation

31,000


65,000

          Changes in:




               Accounts receivable and other current receivables

(259,000)


440,000

               Unbilled receivables

(367,000)


               Inventories

282,000


(724,000)

               Prepaid expenses and other assets

(8,000)


(65,000)

               Accounts payable, accrued expenses and deferred rent

(422,000)


(512,000)

               Deferred revenue

106,000


36,000

               Income taxes receivable and payable

(6,000)


39,000

Net cash used in operating activities

(646,000)


(791,000)

Cash flows from investing activities:




     Purchase of investments

(329,000)


     Purchases of equipment

(15,000)


(48,000)

     Proceeds from sale of real estate held for sale

900,000


     Proceeds from sale of equipment

6,000


     Increase in intangibles

(40,000)


Net cash provided by (used in) investing activities

522,000


(48,000)

Cash flows from financing activities:




     Proceeds from exercise of stock options


50,000

     Principal payments on capital lease and bank term loan

(2,000)


(774,000)

Net cash used in financing activities

(2,000)


(724,000)

Net decrease in cash

(126,000)


(1,563,000)

Cash, beginning of period

1,680,000


4,112,000

Cash, end of period

$1,554,000


$2,549,000

Supplemental Information




Cash payments for interest

$4,000


$9,000

Cash payments for income taxes

$7,000


$5,000

SOURCE Pro-Dex, Inc.

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Digital transformation is about embracing digital technologies into a company's culture to better connect with its customers, automate processes, create better tools, enter new markets, etc. Such a transformation requires continuous orchestration across teams and an environment based on open collaboration and daily experiments. In his session at 21st Cloud Expo, Alex Casalboni, Technical (Cloud) Evangelist at Cloud Academy, explored and discussed the most urgent unsolved challenges to achieve f...
With tough new regulations coming to Europe on data privacy in May 2018, Calligo will explain why in reality the effect is global and transforms how you consider critical data. EU GDPR fundamentally rewrites the rules for cloud, Big Data and IoT. In his session at 21st Cloud Expo, Adam Ryan, Vice President and General Manager EMEA at Calligo, examined the regulations and provided insight on how it affects technology, challenges the established rules and will usher in new levels of diligence arou...
To get the most out of their data, successful companies are not focusing on queries and data lakes, they are actively integrating analytics into their operations with a data-first application development approach. Real-time adjustments to improve revenues, reduce costs, or mitigate risk rely on applications that minimize latency on a variety of data sources. In his session at @BigDataExpo, Jack Norris, Senior Vice President, Data and Applications at MapR Technologies, reviewed best practices t...
In his general session at 21st Cloud Expo, Greg Dumas, Calligo’s Vice President and G.M. of US operations, discussed the new Global Data Protection Regulation and how Calligo can help business stay compliant in digitally globalized world. Greg Dumas is Calligo's Vice President and G.M. of US operations. Calligo is an established service provider that provides an innovative platform for trusted cloud solutions. Calligo’s customers are typically most concerned about GDPR compliance, application p...
Mobile device usage has increased exponentially during the past several years, as consumers rely on handhelds for everything from news and weather to banking and purchases. What can we expect in the next few years? The way in which we interact with our devices will fundamentally change, as businesses leverage Artificial Intelligence. We already see this taking shape as businesses leverage AI for cost savings and customer responsiveness. This trend will continue, as AI is used for more sophistica...
In his Opening Keynote at 21st Cloud Expo, John Considine, General Manager of IBM Cloud Infrastructure, led attendees through the exciting evolution of the cloud. He looked at this major disruption from the perspective of technology, business models, and what this means for enterprises of all sizes. John Considine is General Manager of Cloud Infrastructure Services at IBM. In that role he is responsible for leading IBM’s public cloud infrastructure including strategy, development, and offering m...
Smart cities have the potential to change our lives at so many levels for citizens: less pollution, reduced parking obstacles, better health, education and more energy savings. Real-time data streaming and the Internet of Things (IoT) possess the power to turn this vision into a reality. However, most organizations today are building their data infrastructure to focus solely on addressing immediate business needs vs. a platform capable of quickly adapting emerging technologies to address future ...
"Evatronix provides design services to companies that need to integrate the IoT technology in their products but they don't necessarily have the expertise, knowledge and design team to do so," explained Adam Morawiec, VP of Business Development at Evatronix, in this SYS-CON.tv interview at @ThingsExpo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
In his session at 21st Cloud Expo, Raju Shreewastava, founder of Big Data Trunk, provided a fun and simple way to introduce Machine Leaning to anyone and everyone. He solved a machine learning problem and demonstrated an easy way to be able to do machine learning without even coding. Raju Shreewastava is the founder of Big Data Trunk (www.BigDataTrunk.com), a Big Data Training and consulting firm with offices in the United States. He previously led the data warehouse/business intelligence and B...
Most technology leaders, contemporary and from the hardware era, are reshaping their businesses to do software. They hope to capture value from emerging technologies such as IoT, SDN, and AI. Ultimately, irrespective of the vertical, it is about deriving value from independent software applications participating in an ecosystem as one comprehensive solution. In his session at @ThingsExpo, Kausik Sridhar, founder and CTO of Pulzze Systems, discussed how given the magnitude of today's application ...
DevOps promotes continuous improvement through a culture of collaboration. But in real terms, how do you: Integrate activities across diverse teams and services? Make objective decisions with system-wide visibility? Use feedback loops to enable learning and improvement? With technology insights and real-world examples, in his general session at @DevOpsSummit, at 21st Cloud Expo, Andi Mann, Chief Technology Advocate at Splunk, explored how leading organizations use data-driven DevOps to clos...
The 22nd International Cloud Expo | 1st DXWorld Expo has announced that its Call for Papers is open. Cloud Expo | DXWorld Expo, to be held June 5-7, 2018, at the Javits Center in New York, NY, brings together Cloud Computing, Digital Transformation, Big Data, Internet of Things, DevOps, Machine Learning and WebRTC to one location. With cloud computing driving a higher percentage of enterprise IT budgets every year, it becomes increasingly important to plant your flag in this fast-expanding busin...
Nordstrom is transforming the way that they do business and the cloud is the key to enabling speed and hyper personalized customer experiences. In his session at 21st Cloud Expo, Ken Schow, VP of Engineering at Nordstrom, discussed some of the key learnings and common pitfalls of large enterprises moving to the cloud. This includes strategies around choosing a cloud provider(s), architecture, and lessons learned. In addition, he covered some of the best practices for structured team migration an...
Recently, REAN Cloud built a digital concierge for a North Carolina hospital that had observed that most patient call button questions were repetitive. In addition, the paper-based process used to measure patient health metrics was laborious, not in real-time and sometimes error-prone. In their session at 21st Cloud Expo, Sean Finnerty, Executive Director, Practice Lead, Health Care & Life Science at REAN Cloud, and Dr. S.P.T. Krishnan, Principal Architect at REAN Cloud, discussed how they built...
The “Digital Era” is forcing us to engage with new methods to build, operate and maintain applications. This transformation also implies an evolution to more and more intelligent applications to better engage with the customers, while creating significant market differentiators. In both cases, the cloud has become a key enabler to embrace this digital revolution. So, moving to the cloud is no longer the question; the new questions are HOW and WHEN. To make this equation even more complex, most ...